Cipla Limited (BOM:500087)
India · Delayed Price · Currency is INR 1,359.75
-1.25 (-0.09%)
At close: Sep 16, 2026
Cipla Market Cap
Cipla has a market cap or net worth of 1.09 trillion as of September 16, 2026. Its market cap has decreased by -12.73% in one year.
Market Cap
1.09T
Enterprise Value
998.14B
Revenue
280.68B
Ranking
n/a
PE Ratio
32.38
Stock Price
1,359.75
ChartMarket Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.09T, an increase of 72,001.73%. That is a compound annual growth rate of 24.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 1.09T | -10.60% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.89T |
| Dr. Reddy's Laboratories | 967.09B |
| Lupin | 958.36B |
| Abbott India | 543.69B |
| GlaxoSmithKline Pharmaceuticals | 480.64B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |